Mironova Labs

Distribution Partnership with Mironova Labs

Differentiated specialty chemical lines spanning pharma, semiconductor, and cosmetic markets — all US-manufactured from our Fairfield, NJ facility with full technical support

For chemical distributors seeking specialty product lines with defensible positioning, published science, and domestic supply chain security

Discuss Distribution Partnership Explore Our Science

Product Lines

90+

Catalog Compounds

1988

Established

NJ, USA

Manufacturing Base

Supported by peer-reviewed research·US-manufactured (Fairfield, NJ)·5 product lines·35+ years manufacturing·Technical support included

Mironova manufactures five specialty product lines from our Fairfield, NJ facility: DMTMM coupling reagents, prostaglandins, TMHD metal-organic precursors, hair enhancement actives, and L-ergothioneine. Each line occupies a distinct market niche with published performance data and dedicated technical support. This page outlines the partnership model, product portfolio, and market opportunity for distribution partners.

Full Product Catalog Science Overview About Mironova

Challenges & Solutions

Your Challenge. Our Answer.

We understand the specific problems you face — and we built solutions for each one.

The Problem

Generic fine chemical portfolios are commoditized — margins compress when you sell the same products as every other distributor

Mironova’s Answer

Mironova’s five product lines each occupy defensible niches: DMTMM is the only commercial triazine coupling reagent at ≥99% purity, our TMHD precursors are halide-free alternatives for ALD/CVD, and our hair actives are non-prostaglandin alternatives in a tightening regulatory environment

The Problem

Supply chain risk from overseas-only manufacturers creates fulfillment uncertainty, long lead times, and IP exposure

Mironova’s Answer

All core products are manufactured and QC’d in Fairfield, NJ. Typical lead times are 2–4 weeks for catalog quantities. Full CoA documentation ships with every order.

2–4 week lead times

The Problem

Technical support burden falls on distributors who lack deep application expertise for specialty chemicals

Mironova’s Answer

Mironova provides dedicated science hubs, application protocols, and pre-sales technical guidance for each product line — your team gets the tools to lead customer conversations with science, not just price

Published Research

Published Evidence

Key findings from peer-reviewed literature relevant to your application.

Peer-Reviewed Performance Data

DMTMM coupling reagents are supported by published SPPS and fragment coupling data (Kamiński, J. Am. Chem. Soc. 2005; Sperry, Org. Process Res. Dev. 2018). TMHD precursors have published ALD deposition data. Each product line has a dedicated science hub with citations your customers can verify.

Kamiński et al. 2005; Sperry et al. 2018; mironova.com/science

Multi-Sector Market Tailwinds

Three product lines in $1B+ addressable markets

Peptide synthesis reagents: ~$730M (2024) → ~$1.5B (2034), driven by GLP-1 therapeutics. ALD/CVD precursors: ~$1.7–1.9B (2024) with ~9% CAGR, accelerated by CHIPS Act fab investment. Ergothioneine supplements growing as longevity category expands.

Global Market Insights; TECHCET 2024; Mironova market analysis

35+ Years Manufacturing Heritage

Mironova has manufactured prostaglandins since 1988, scaling from research quantities to multi-kg campaigns. The same Fairfield, NJ facility now produces coupling reagents, ALD precursors, cosmetic actives, and ergothioneine — all under one quality system.

Mironova Labs corporate history

Market Context

Specialty Chemicals Are Outpacing Commodity Distribution

The specialty chemical distribution market favors suppliers with technical differentiation and domestic manufacturing. GLP-1 peptide therapeutics, CHIPS Act semiconductor expansion, MoCRA cosmetic regulation, and the longevity supplement wave are creating demand for exactly the product categories Mironova manufactures. Distributors positioned in these niches now can build defensible customer relationships before these markets mature.

GLP-1 manufacturing expansion is driving unprecedented demand for high-purity coupling reagents
CHIPS Act is funding new US fabs that need domestic ALD/CVD precursor supply chains
MoCRA is raising the bar for cosmetic ingredient documentation — favoring suppliers with published data

Global Market Insights; TECHCET 2024; FDA MoCRA guidance

~$1.5B

Peptide reagent market by 2034

~9%

ALD precursor CAGR

Distinct end markets served

Product Catalog

Partnership Model

Every product line ships with dedicated science hub access, CoA documentation, application protocols, and technical selling guides. Your team can field customer questions on mechanism, purity, and applications without escalating to Mironova.

For complex customer inquiries — solvent compatibility, deposition parameters, formulation guidance — our technical team provides direct pre-sales support. We help you close, not just quote.

Distributor pricing is structured by product line and volume tier. Margins reflect the specialty positioning of each product. Volume commitments unlock additional pricing support and priority allocation.

Minimum order quantities start at 25–50 g depending on product line, with catalog quantities shipping in 2–4 weeks. Multi-kg campaigns are quoted on request with 6–8 week lead times.

White-label and custom packaging options are available for qualified distribution partners, including custom lot sizes, branded labels, and region-specific documentation.

We provide product brochures, comparison charts, webinar recordings, and on-request sales training sessions to bring your team up to speed on each product line’s technical differentiation.

Why Mironova

Your Advantage with Mironova

Five Differentiated Product Lines

DMTMM coupling reagents, prostaglandin analogs, TMHD metal-organic precursors, hair enhancement actives, and L-ergothioneine — each in a distinct market with limited competitive overlap.

Science-Backed Selling

Every product line has published peer-reviewed data and a dedicated science hub. Your sales team leads with evidence — citations, comparative data, application protocols — not just price.

US Manufacturing, 2–4 Week Lead Times

Core products manufactured and QC’d in Fairfield, NJ. Catalog orders ship in 2–4 weeks. Multi-kg campaigns quoted on request. Full CoA with every shipment.

Three $1B+ Addressable Markets

Peptide reagents (~$730M → $1.5B), ALD precursors (~$1.7B at 9% CAGR), and ergothioneine/longevity supplements are all expanding. Your investment in these lines grows with the market.

Request Technical Data

Get product specifications, CoA samples, and pricing for your evaluation.

FAQ

Frequently Asked Questions

Common technical questions about this product line, answered by our scientific team.

Territory availability depends on your market and the product line. Contact our business development team to discuss open territories and partnership structures.

We provide distributor pricing with competitive margins. Specific pricing depends on product line, territory, and volume commitments. We structure partnerships to support your sales investment with technical training and marketing materials.

Yes. We provide product training, application guides, and technical support to help your team communicate the scientific differentiation of our product lines to end customers.

DMTMM coupling reagents (driven by GLP-1 peptide manufacturing demand), TMHD precursors (driven by CHIPS Act fab expansion), and ergothioneine (driven by longevity supplement trends) all have strong market tailwinds. Hair enhancement actives benefit from the non-PG alternative demand as prostaglandin regulations tighten.